Research theme for competitive and other funds (2)：
2019 - 2022 末梢TH17細胞の活性化が脳機能に与える影響の解明
2017 - 2018 樹状突起スパインにおけるミオシンファミリーの機能解析
Papers (14)：
Kazunori Utsunomiya, Ryusuke Koshida, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, Kohei Kaku. Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT). Journal of Diabetes Investigation. 2021. 12. 2. 184-199
Kazunori Utsunomiya, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, Ryusuke Koshida, Hiroyuki Kameda, Masahiro Tamura, Kohei Kaku. Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24-month interim analysis of a long-term post-marketing study (J-STEP/LT). Journal of Diabetes Investigation. 2020. 11. 4. 906-916
Hideaki Kaneto, Ryusuke Koshida, Mike Baxter. Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge. Diabetes, Obesity and Metabolism. 2020. 22. 4. 24-34
Lectures and oral presentations (2)：
Myosin1d localizes in dendritic spines through the tail homology 1 domain
(第41回日本神経科学大会 2018)
MafBは後脳脈絡叢の正常な形成に必須である
(第122回 日本解剖学会総会・学術集会 2017)
Education (2)：
2012 - 2016 University of Tsukuba Graduate School of Comprehensive Human Sciences
2004 - 2010 University of Miyazaki Faculty of Medicine School of Medicine
Professional career (1)：
博士(医学) (筑波大学)
Work history (2)：
2016/04 - 2019/03 University of Tsukuba Faculty of Medicine
